Tag: Dr. GSK Velu

Photo 1 - (R to L) Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics with MS Dhoni, Former India Skipper
Health, News

Neuberg Diagnostics partners with MS Dhoni to send the message of health and wellness

Aug 17, 2021 by Rekha Nair 0 Comments #Chairman and Managing Director, #Dr. GSK Velu, #Former India Skipper and Captain of Chennai Super Kings, #MS Dhoni, #Neuberg Diagnostics

Hyderabad: Neuberg Diagnostics, India’s fourth-largest diagnostic lab chain, today announced that it has partnered with ace cricketer, MS Dhoni, for creating awareness about Neuberg’s health and wellness campaign and conveying its efforts towards empowering every citizen with better and affordable healthcare.

Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics, said, “MS Dhoni complements our growth mindset, and thus is a strategic fit during our growth years. We are excited about this association and are honored to have him on board as our evangelist and global brand ambassador. We are keen to take our plethora of diagnostic services across the country and convey our efforts towards empowering every citizen with better and affordable healthcare. Furthermore, Dhoni’s commitment towards maintaining good health and fitness resonates well with our mission and will remind people to prioritize their health. Dhoni’s backing will enable us to communicate about our commitment and services more effectively.”

MS Dhoni, Former India Skipper and Captain of Chennai Super Kings, said, “The leaders at Neuberg are committed to providing affordable healthcare across India, and that really struck me and it’s a pleasure to be associated with the team and their various programs aimed at providing access to quality and affordable healthcare. Amidst the Covid-19 pandemic, they have taken up the campaign to raise awareness about health and wellness across age groups. I personally feel that these efforts are important and deserve to be advocated.”

On the back of growing footprints, the company has been seeing robust growth. In a matter of four years since its inception, with a presence in three continents, the company ended its FY21 with revenues of Rs.800 crore, and on the back of its differentiated offerings, it is aiming to close FY22 with revenues of Rs.1000 crore with more than 200 labs and 3000 collection centers, located across the world.

MS Dhoni will also enable the company to generate recall across its global markets in the UAE, South Africa and the USA.

Test kit
Business World

Trivitron responds to PM Modi’s call for ‘Atmanirbhar Bharat’ to provide indigenous COVID-19 testing kits globally

Aug 10, 2020 by Gouri Achary 0 Comments #Atmanirbhar (self-reliant) Bharat., #Chairman and Managing Director, #COVID-19, #Dr. GSK Velu, #Trivitron Healthcare, #Vocal for Local’

New Delhi –August 10, 2020: In the global uncertainty of COVID-19, healthcare industry leader- Trivitron Healthcare, counts for the continuity of services & solutions for COVID-19. Responding to the honourable Prime Minister Modi’s call for ‘Vocal for Local’, Trivitron Healthcare as a leading domestic health technology company, is pleased to announce the launch of a full suite of indigenously developed COVID-19 Testing products, as the organization’s contribution towards Atmanirbhar (self-reliant) Bharat.

Trivitron Healthcare offers a comprehensive range of ICMR approved COVID-19 solutions including RT-PCR Tests (COVIDsure&COVIDsure Pro), RNA Extraction kits (RNAsure), Viral Transport Media (ViSure), Total Antibody ELISA Test (COVIDscreen Plus) and ELISA IgG (COVID Kavach IgG) testing kits for Covid-19.

Realizing the enormous need of testing kits in the domestic market, to address this, the organization has indigenously designed & developed and had started large scale manufacturing for COVID-19 RT‑PCR test kits, RNA Extraction kits, Viral Transport Media, ELISA Antibody Tests, and will soon be launching Rapid POC Tests as well, for the Indian market. Trivitron is committed to manufacturer cost-effective and globally-accepted high-quality kits, and other COVID-19 solutions.

“We have been focused on making world-class Made-in-India medical technology solutions for domestic and global markets. The current situation of COVID-19 pandemic demanded innovation in developing indigenous and economical testing kits for the Indian market and we have responded to this. We have a complete range of COVID testing portfolio which will enable scaling up of current testing needs of the Indian & International Healthcare Ecosystem.’’ said, Dr. GSK Velu, Chairman and Managing Director, Trivitron Healthcare.

Trivitron has been tracking the alarming spread of COVID-19 since the world media started reporting its devastating impact on China. Trivitron as a torchbearer of the ‘Make in India’ initiative and supporting the leadership’s call for a self-reliant nation, has decided to accelerate and enhance products and countermeasures to combat the spread of COVID‑19 in India.

By March 2020, efforts were upscaled to indigenously create required solutions, without losing time, within the given constraints and available resources, at Trivitron’s state-of-the-art facilities – Trivitron Medical Technology Park, Chennai, and AMTZ, Vishakhapatnam. As a result of this approach, Trivitron is the only Indian organization that is ready with a complete portfolio of indigenously developed technologies which can be utilized for combating COVID-19 and to fulfil the low-cost testing needs for the country, and with indigenously manufactured Comprehensive COVID-19 testing solutions, ensuring the best suppliers across the world.